Effectiveness and safety of risperidone for children and adolescents with chronic tic or tourette disorders in Korea

Journal of Child and Adolescent Psychopharmacology

Volumn 15, Issue 2, 2005, Pages 318-324

  Kim, Boong Nyun ^a   Lee, Chung Bum ^a   Hwang, Jun Won ^a   Shin, Min Sub ^a   Cho, Soo Churl ^a  

^a Seoul National University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

HALOPERIDOL; PIMOZIDE; RISPERIDONE;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; COMORBIDITY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; GILLES DE LA TOURETTE SYNDROME; HUMAN; KOREA; MALE; OBSESSIVE COMPULSIVE DISORDER; PSYCHIATRIC DEPARTMENT; SCORING SYSTEM; SEDATION; SHORT COURSE THERAPY; SIDE EFFECT; TIC;

ADOLESCENT; ANALYSIS OF VARIANCE; CHILD; CHRONIC DISEASE; FEMALE; HUMANS; KOREA; MALE; RISPERIDONE; TIC DISORDERS; TOURETTE SYNDROME;

EID: 19544382891     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2005.15.318     Document Type: Article

References (24)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington (DC), APA Press, 1994.
2. Bruggeman R, van der Linden C, Buitelaar JK, Gericke GS, Hawkridge SM, Temlett JA: Risperidone versus pimozide in Tourette's Disorder: A comparative, double-blind, parallel-group study. J Clin Psychiatry 62:50-56, 2001.
3. Brunn RD: Dysphoric phenomena associated with haloperidol treatment of Tourette syndrome. Adv Neurol 35:433-436, 1982.
4. Brunn RD: Gilles de la Tourette syndrome: An overview of clinical experience. J Am Acad Child Psychiatry 23:126-133, 1984.
5. Brunn RD: Subtle and under-recognized side effects of neuroleptic treatment in children with Tourette's Disorder. Am J Psychiatry 145:621-624, 1988.
6. Brunn RD, Budman CL: Risperidone as a treatment for Tourette syndrome. J Clin Psychiatry 57:29-31, 1996.
7. Cho S-C: Child and Adolescent Psychopharmacology, 2nd ed. Seoul National University Press, Seoul, 2000, pp. 380-381.
8. Chouinard G, Jones B, Remington G: A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients. J Clin Psychopharmacol 13:25-40, 1993.
9. Cohen DJ, Detlor J, Young JG, Shaywitz BA: Clonidine ameliorates Gilles de la Tourette syndrome. Arch Gen Psychiatr 37:1350-1357, 1980.
10. Dion Y, Annable L, Sandor P, Chorinard G: Risperidone in the treatment of Tourette syndrome: A double-blind, placebo-controlled trial. J Clin Psychopharmacol 22:31-39, 2002.
11. Goetz CG, Tanner CM, Wilson RS, Carroll VS: Clonidine and Tourette syndrome: Double-blind study using objective rating methods. Ann Neurol 21:307-310, 1987.
12. Leyesn JE, Gommeren W, Eens A, De Chaffoy D, Stoof JC, Janssen PA: Biochemical profile of risperidone, a new antipsychotic. J Pharmacol Exp Ther 247:661-670, 1988.
13. Lombroso PJ, Scahill L. King RA, Leckman JF: Risperidone treatment of children and adolescents with chronic tic disorder: A preliminary report. J Am Acad Child Adolesc Psychiatry 34:1147-1152, 1995.
14. Marder SR, Meibach RC: Risperidone in the treatment of schizophrenia. Am J Psychiatry 151:825-835, 1994.
15. Pauls DL, Leckman JF, Cohen DJ: The familial relationship between Gilles de la Tourette syndrome, attention-deficit disorder, learning disabilities, speech disorders, and stuttering. J Am Acad Child Adolesc Psychiatry 32:1044-1050, 1993.
16. Pauls DL, Raymond CL, Stevenson J, Leckman JF: A family study of Tourette syndrome. Am J Hum Genet 48:154-163, 1991.
17. Robertson MM, Scull DA, Eapen V, Trimble MR: Risperidone in the treatment of Tourette syndrome: A retrospective case note study. J Psychopharmacol 10:317-320, 1996.
18. Sadock BJ, Sadock VA: Comprehensive Textbook of Psychiatry, 7th ed. Lippincott Williams & Wilkins, Philadelphia, 2000, pp. 2433-2434.
19. Singer HS, Gammon K, Quaskey S: Haloperidol, fluphenazine, and clonidine in Tourette syndrome: Controversies in treatment. Ped Neurosci 12:71-74, 1986.
20. Scahill L, Leckman JF, Schultz RT, Katsovich L, Peterson BS: A placebo-controlled trial of risperidone in Tourette syndrome. Neurology 60:1130-1135, 2003.
21. Stamenkovic M, Aschauer H, Kasper S: Risperidone for Tourette syndrome. Lancet 344:1577-1578, 1994.
22. Sumiyoshi T, Kido H, Sakamoto H, Yamaguchi N, Mori H, Shiba K, Yokagama K: In vivo dopamine-D2 and serotonin-5-HT2 receptor binding study of risperidone and haloperidol. Pharmacol Biochem Behav 47:553-557, 1994.
23. Van der Linden C, Bruggeman R, Van Woerkom T: Serotonine-dopamine antagonist and Gilles de la Tourette syndrome: An open pilot, dose-titration study with risperidone. Mov Disord 98:687-688, 1994.
24. World Health Organization: International Classification of Diseases, 10th ed. World Health Organization Geneva, 1992.